Response to: 'The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients' by Favalli <i>et al</i>.

Romão, Vasco C; Cruz-Machado, Ana Rita; Fonseca, João Eurico

Response to: 'The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients' by Favalli et al.

Romão, Vasco C; Cruz-Machado, Ana Rita; Fonseca, João Eurico.

Romão VC; Rheumatology Department, Hospital de Santa Maria, CHULN, Lisbon Academic Medical Centre, Lisbon, Portugal.
Cruz-Machado AR; Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Fonseca JE; Rheumatology Department, Hospital de Santa Maria, CHULN, Lisbon Academic Medical Centre, Lisbon, Portugal.

Ann Rheum Dis ; 80(5): e76, 2021 05.

Article in English | MEDLINE | ID: covidwho-1309812

Subject(s)

Antimalarials; Arthritis, Rheumatoid; COVID-19; Antimalarials/therapeutic use; Arthritis, Rheumatoid/drug therapy; Humans; Hydroxychloroquine/therapeutic use; SARS-CoV-2

Keywords

arthritis, rheumatoid; epidemiology; hydroxychloroquine; lupus erythematosus, systemic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Arthritis, Rheumatoid / COVID-19 / Antimalarials Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-218175

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google